Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccines in urologic malignancies.

D R Siemens, T L Ratliff

    Urological Research
    |August 3, 2001
    PubMed
    Summary

    Cancer immunotherapy, particularly cancer vaccines, shows promise for treating neoplastic disease. Advances in tumor immunology and antigen identification are crucial for developing effective cancer vaccine therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.

    The Journal of urology·2023
    Same author

    1α, 25 Dihydroxyvitamin D (1,25(OH)<sub>2</sub>D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC).

    The Journal of steroid biochemistry and molecular biology·2019
    Same author

    Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2017
    Same author

    Patterns of Referral to Radiation Oncology among Patients with Bladder Cancer: a Population-based Study.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2016
    Same author

    Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.

    Oncogene·2016
    Same author

    Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer.

    Oncogene·2016

    Area of Science:

    • Oncology
    • Immunology
    • Vaccinology

    Background:

    • Cancer immunotherapy has been explored for over a century, yet its full potential remains largely untapped, particularly for non-urologic malignancies.
    • Tumors express antigens that can serve as targets for anti-tumor immunity, fueling renewed interest in cancer vaccines.

    Discussion:

    • Understanding tumor immunology, including immune surveillance, antigen presentation, and tumor escape mechanisms, is vital for advancing cancer vaccine therapy.
    • Active immunotherapy has shown success in animal models, paving the way for clinical trials of cancer vaccines.

    Key Insights:

    • Identifying unique, tumor-specific antigens is essential for stimulating T cell responses.
    • Successful cancer vaccines require effective antigen presentation to elicit a robust anti-tumor immune response.

    Outlook:

    • Continued research into tumor immunology and antigen discovery will drive the development of novel cancer vaccine therapies.
    • Further investigation into the successes and limitations of vaccine therapy, especially for urologic malignancies, is warranted.

    Related Experiment Videos